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Introduction
Brown tumour, a giant cell granuloma occurring in osteitis 
fibrosis cystica, represents the terminal stage of the bone 
remodelling processes occurring as a result of peritrabecular 
fibrosis and osteoclastic activity.1 Brown tumours may 
contain necrotic centres and haemosiderin deposition, 
which gives them their characteristic colour. The lesions tend 
to be found in areas of increased bone resorption, the most 
common sites being the femur, pelvis, ribs and mandible. 
Involvement of the maxilla is relatively rare, accounting for 
4.5 to 11.8% of brown tumours.2-5 Brown tumours have 
been reported to occur in approximately 4.5% of patients 
with primary hyperparathyroidism (HPT), but they very rarely 
are the presenting feature.6,7 The presentation of parathyroid 
carcinoma with a brown tumour of the mandible or maxilla 
has been described in previous case reports.5,8,9 We report 
an unusual case of parathyroid carcinoma presenting with 
HPT and a brown tumour in the maxilla.
Case report
A 62-year-old man with a long history of nasal polyposis 
and multiple polypectomies presented with a large swelling 
between the nose and the eye on the right side (Figure 1). The 
swelling caused right-sided nasal obstruction, intermittent 
bleeding and diplopia. His past medical history included 
essential hypertension, transient ischaemic attacks, 
acute myocardial infarction and asthma. Bone mineral 
densitometry and a skeletal survey were not performed. A 
computed tomography (CT) scan (Figure 2) demonstrated 
an extensive, destructive soft tissue mass centred on the 
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Abstract
This is a report of a maxillary brown tumour caused by primary hyperparathyroidism (HPT) secondary to parathyroid 
carcinoma. A 62-year-old man presented with a large swelling in the right maxilla, which caused right-sided nasal obstruction, 
intermittent bleeding and diplopia. A computed tomography scan demonstrated an expansible, destructive soft tissue mass 
centred on the right ethmoid sinus, extending from the maxilla to the orbital floor. Histology showed a central giant cell 
granuloma of bone, thought to be a brown tumour of HPT and this was supported by serum calcium of 3.0 mmol/l and serum 
parathyroid hormone of 880 ng/l (normal 7 to 40 ng/l). Parathyroid imaging was consistent with a left lower parathyroid 
adenoma. The patient underwent removal of the parathyroid gland, left hemithyroidectomy and central node dissection. 
Histology confirmed parathyroid carcinoma. Surgical removal of the brown tumour was offered but declined. The symptoms 
improved and the maxillary swelling gradually reduced in size. The management of brown tumours is controversial, but a 
pragmatic approach is essential to a successful outcome. The general consensus seems to be adequate treatment of the 
HPT and surgical excision of the brown tumour only if the mass effect of the lesion is troublesome.
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Figure 1: Photograph of patient’s face showing mass between right eye 
and nose
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right ethmoid sinus, extending from the maxilla to the orbital 
floor.
Under general anaesthesia, a biopsy was obtained for 
histological examination. This showed collections of 
multinucleated osteoclast-like giant cells in a richly vascular 
spindle cell stroma, with no features of malignancy. A central 
giant cell granuloma of bone was diagnosed, and HPT was 
suggested as a possible underlying cause. 
Blood analysis revealed a raised total alkaline phosphatase 
of 191 IU/l (normal range 1 to 74 IU/l), serum calcium of 
3.51 mmol/l, serum phosphate of 0.53 mmol/l, creatinine 
of 123 µmol/l and serum parathyroid hormone (PTH) of 
827 ng/l (normal range 7 to 40 ng/l). Urinary examination 
for calcium excretion and assessment of vitamin D status 
were not performed. A diagnosis of brown tumour due 
to primary HPT was made. Evaluation of the parathyroid 
glands was performed using ultrasound and technetium 
methoxyisobutylisonitrile (Tc MIBI) scan. While the former 
was normal, the latter showed intense uptake of tracer 
projected over the left lower thyroid lobe, consistent with a 
parathyroid adenoma.
The patient underwent removal of the parathyroid gland, left 
hemithyroidectomy and central node dissection. Histology 
confirmed parathyroid carcinoma with extensive capsular 
invasion, but clear margins (2 mm) and central lymph nodes. 
Postoperatively the patient developed hypocalcaemia (1.94 
mmol/l), which was managed with oral calcium. His serum 
PTH decreased to 115 ng/l. Surgical removal of the brown 
tumour was offered but declined.
Examination at one year postoperatively showed resolution 
of the diplopia, slight reduction in the size of the brown 
tumour and no evidence of recurrence on whole body 
Tc MIBI and neck ultrasound. Follow-up CT imaging three 
years postoperatively (Figure 3) demonstrated a dramatic 
decrease in the size of the lesion and its associated 
mass effects, but with an unusual “ground glass” 
appearance attributable to the secondary ossification of 
the large tumour, thought to be healing by fibrosis. Six 
years postoperatively he remained asymptomatic, but 
with only partial regression of the mass, as expected, 
due to the ossification of the lesion. There was no 
evidence of recurrence of the parathyroid carcinoma, 
and the PTH level was 41.44 ng/l (normal range 15 to 
65 ng/l). Subsequent renal ultrasonography revealed two 
benign cysts in the right kidney.
Discussion
The biochemical profile of HPT has evolved in recent times, 
such that the typical presentation is now of asymptomatic 
hypercalcaemia.10 Patients with undiagnosed HPT 
presenting with severe bone disease such as a brown 
tumour are becoming increasingly less common as a result 
of earlier diagnosis and improved treatment.11 
This case posed two diagnostic challenges. Firstly, 
identifying primary HPT as the cause of the tumour, and 
secondly, identifying parathyroid carcinoma as the cause of 
the primary HPT prior to surgery.
Histology alone is insufficient to establish a diagnosis 
of brown tumour of HPT, as the appearances are 
Figure 3: Computerised tomography image of brown tumour three 
years after parathyroidectomy. The brown tumour can be seen 
invading the ethmoid air cells and medial wall of the orbit
Figure 2: Computerised tomography image of brown tumour shortly 
after presentation
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similar to other giant cell lesions such as giant cell 
reparative granuloma, giant cell tumour, osteoblastoma, 
chondroblastoma, aneurysmal bone cyst and cherubism.12 
Radiological appearances of brown tumours in the facial 
bones (well-defined radiolucent osteolytic lesions) are 
not pathognomonic.12 Diagnosis therefore is based on 
biochemical evidence of HPT and compatible histological 
and radiological features. Unless a brown tumour secondary 
to HPT is considered in the differential diagnosis of a 
giant cell bony lesion, its diagnosis would be delayed or 
missed. With brown tumours becoming less common, an 
increasingly high index of suspicion is required.
Identifying parathyroid carcinoma as a cause of primary 
HPT is notoriously difficult to establish, as it is both rare 
and presents with a clinical and biochemical profile similar 
to benign parathyroid disorders.9,13 Therefore the diagnosis 
is often made intraoperatively or postoperatively.14 The 
presence of markedly raised serum calcium and PTH levels, 
a palpable mass and severe clinical presentation should 
raise the suspicion of parathyroid carcinoma.13-15 As there 
was no palpable parathyroid mass in the present case, 
and the radiological findings did not suggest carcinoma as 
a cause of HPT, the diagnosis was made intraoperatively 
and confirmed on histological examination. The diagnosis 
of parathyroid carcinoma in this case meets with the strict 
criteria recommended by DeLellis, as there was invasion of 
adjacent structures.16 
In this unusual case the investigation of an uncommon 
maxillary bony lesion led to the diagnosis of primary HPT 
due to a parathyroid carcinoma. 
This case demonstrates a compatible clinical picture of 
the hyperparathyroidism-jaw tumour (HPT-JT) syndrome17 
(hyperparathyroidism, parathyroid carcinoma, maxillary 
brown tumour and renal cysts), but the lack of analysis for the 
HRPT2 gene makes the diagnosis inconclusive.17,18 Genetic 
studies of familial HPT have determined several subgroups 
of the disease: multiple endocrine neoplasia (MEN) 1, 
MEN 2, familial benign hypocalciuric hypercalcaemia, 
and the HPT-JT syndrome. HPT-JT syndrome, the least 
common and least well-known type of familial HPT, is an 
autosomal dominant disease caused by inactivating germ-
line mutations of the HRPT2 gene with subsequent loss of 
parafibromin expression.19 It is characterised by particularly 
marked hypercalcaemia and association with parathyroid 
carcinoma in 15% of the cases.19,20 In the light of recent 
reports,17,18,20,21 further investigation and possibly screening 
of family members would be helpful in confirming the 
syndrome and ensuring early diagnosis.
There is controversy regarding the appropriate management 
of brown tumours. Reporting on a series of 21 patients 
with brown tumours, Resendiz-Colosia and co-workers 
concluded that the natural history is spontaneous regression, 
either partial or complete after correction of HPT.22 This 
position is supported by other case reports.23-25 In certain 
circumstances, particularly where the tumour involves the 
facial bones or the spinal canal, this benign tumour can 
cause direct morbidity and mortality.24,26 Proimos et al27 
advocated excision of brown tumour in case of continued 
growth in spite of parathyroidectomy or where tumour size 
caused incapacity. Others advocate the correction of HPT, 
as well as surgical removal of the bone lesion.2,28 Although 
the patient in this case had significant symptoms of nasal 
obstruction, bleeding and diplopia, all related to the brown 
tumour, he declined surgical removal. Follow-up over six 
years after parathyroidectomy and the correction of HPT 
confirmed a partial response, suggesting that even those 
cases with a significant mass effect are likely to regress over 
time and that surgical removal may not be necessary. 
Conclusion
This report adds another case of parathyroid carcinoma 
with a maxillary brown tumour to the literature. A high index 
of suspicion and thorough diagnostic workup are required 
to make a timely diagnosis of both parathyroid carcinoma 
and brown tumour. The management of brown tumours is 
controversial, but a pragmatic approach is essential to a 
successful outcome. The general consensus seems to be 
adequate treatment of the HPT and surgical excision of 
the brown tumour only if the mass effect of the lesion is 
troublesome.
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